Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Presentation Icons
Event Add-on
In Person Only
Off-site Event
Location: Marriott Marquis
Back
Main Session
Favorite
Facebook
Tweet
EDU 19 - Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Questions and Answers
Monday, September 30, 2024
8:47 AM – 9:00 AM
ET
Location: Room 143
Speaker(s)
Chirayu Patel, MD, MD, MPH
Massachusetts General Hospital
Bellingham, MA, United States
Learning Objectives:
Explain the data supporting combined modality treatment in early Hodgkin lymphoma and quantify the benefit for individual patients.
Determine which patients with Primary Mediastinal B-cell Lymphoma benefit from consolidation radiotherapy.
Assess disease and patient factors to select patients for consolidation RT in DLBCL.